세계의 PET 스캐너 시장 - 규모, 점유율, 동향 분석 보고서 : 모달리티별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

PET Scanners Market Size, Share & Trends Analysis Report By Modality (PET-CT, PET-MRI), By Application (Oncology, Cardiology, Neurology), By End Use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,539,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,974,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,845,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

PET 스캐너 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계 PET 스캐너 시장은 2030년까지 33억 7,000만 달러에 이르렀으며, 2024년부터 2030년까지의 CAGR은 3.65%로 확대될 것으로 예상됩니다.

세계 암 환자 증가와 방사성 의약품에 있어서의 PET 분석 수요 증가가 시장 성장을 가속할 것으로 예측되고 있습니다. 디지털 PET 스캐너는 추적기에서 방출되는 방사선의 양을 정확하게 측정할 수 있는 고급 검출기를 사용합니다. 이를 통해 높은 공간 해상도와 시간 해상도를 실현하고 노이즈를 줄여 화질을 향상시킬 수 있습니다. PET와 자기공명영상법(MRI)을 결합하면 신진대사와 해부학적 정보를 동시에 얻을 수 있어 진단의 정확도를 높이고 치료 계획을 수립할 수 있습니다.

게다가 PET 스캐너에서 인공지능(AI)의 이용 확대는 화질 향상, 환자 방사선 노출 감소, 의료 영상 진단의 효율과 정밀도를 높이는 특정 작업의 자동화 등의 가능성이 있습니다. 예를 들어, 2022년 10월, 혁신적인 PET 방사성 의약품의 세계 공급자인 Blue Earth Diagnostics는 AI 기반 알고리즘 개발을 지원하기 위해 선도적인 의료기기 제조업체인 Siemens Hertiners 및 뮌헨 기술 대학대학병원(TUM)과 임상시험용 PET 이미징 약제인 18F-rhPSMA-7.3의 데이터 공유 계약을 체결했습니다. Siemens Healthineers는 혁신적인 PET/CT 이미징 소프트웨어 전체에서 전립선암에 대한 분석과 AI 기반 알고리즘을 개선하기 위해 데이터를 평가할 의향입니다. 그러나 AI 기술의 진보는 계속되고 있으며, 미래에는 PET 스캐너 시장의 성장을 견인할 가능성이 높습니다.

PET 스캐너 시장 보고서 하이라이트

• PET-CT가 PET 스캐너 시장을 독점하고 2023년에는 81.91%의 최대 수익 점유율을 차지합니다.
• 종양학 부문이 우세하고 2023년 최대 수익 점유율은 47.0%
• 병원 부문은 2023년 52.20% 이상의 최대 수익 점유율을 차지했습니다. 병원은 상대적으로 환자 수가 많으며 고급 PET 스캐너와 같은 다른 의료 시설에서는 사용할 수 없는 고급 진단 기술을 활용할 수 있으므로 종합 의료를 제공할 수 있습니다.
• 북미 PET 스캐너 시장은 2023년 34.11% 이상의 최대 수익 점유율을 차지했습니다. 종양학 및 진보된 진단 응용을 위한 PET 이미징의 기술 발전은 정밀 진단에 대한 높은 수요와 함께 시장 성장을 크게 이끌고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 PET 스캐너 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 견인 요인 분석
  • 시장 성장 억제요인 분석
• PET 스캐너 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 파이프라인 분석

제4장 PET 스캐너 시장 : 모달리티별 추정·동향 분석

• 세계의 PET 스캐너 시장 : 모달리티별 대시보드
• 세계의 PET 스캐너 시장 : 모달리티별 변동 분석
• 세계의 PET 스캐너 시장 : 모달리티별 수익
• PET-CT
• PET-MRI

제5장 PET 스캐너 시장 : 용도별 추정·동향 분석

• 세계의 PET 스캐너 시장 : 용도별 대시보드
• 세계의 PET 스캐너 시장 : 용도별 변동 분석
• 세계의 PET 스캐너 시장 추계·예측 : 용도별 수익
• 종양학
  • 종양학 시장 추계·예측 2018-2030년
• 심장병학
  • 심장병 시장 추계·예측 2018-2030년
• 신경학
  • 신경학 시장 추계·예측 2018-2030년
• 기타
  • 기타 시장 추계·예측 2018-2030년

제6장 PET 스캐너 시장 : 최종 용도별 추정·동향 분석

• 세계의 PET 스캐너 시장 : 최종 용도별 대시보드
• 세계의 PET 스캐너 시장 : 최종 용도별 변동 분석
• 세계의 PET 스캐너 시장 추계·예측 : 최종 용도별 수익
• 병원
• 화상 진단센터
• 학술연구기관

제7장 PET 스캐너 시장 : 모달리티, 용도, 최종 용도별 지역별 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석(2018-2030년):
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 기업/경쟁의 분류
• 벤더 상황
  • 주요 리셀러 및 채널 파트너 목록
  • 주요 고객
  • 주요 기업의 시장 점유율 분석, 2023년
  • Canon Medical Systems
  • GE Healthcare
  • Kindsway Biotech
  • Koninklijke Phillips NV
  • Mediso Ltd.
  • PerkinElmer
  • Positron
  • Shimadzu Corporation
  • Siemens Healthineers AG

JHS

영문 목차

영문목차

PET Scanners Market Growth & Trends:

The global PET scanners market is expected to reach USD 3.37 billion by 2030 to expand at a CAGR of 3.65% from 2024 to 2030 based on a new report by Grand View Research, Inc. An increasing prevalence of cancer patients globally and the growing demand for PET analysis in radiopharmaceuticals are expected to propel the growth of the market. Digital PET scanners use advanced detectors that can precisely measure the amount of radiation emitted by the tracer. This allows for higher spatial and temporal resolution, reducing noise and improving image quality. Combining PET and magnetic resonance imaging (MRI) allows for the simultaneous acquisition of metabolic and anatomical information, which can improve the accuracy of diagnosis and helps in planning treatment.

Furthermore, the increased use of artificial intelligence (AI) in PET scanners has the potential to enhance image quality, reduce radiation exposure for patients, and automate certain tasks to improve efficiency and accuracy in medical imaging. For instance, in October 2022, Blue Earth Diagnostics, a global provider of innovative PET radiopharmaceuticals signed an agreement of a data-sharing with Siemens Healthineers, a major medical device company, and the University Hospital of the Technical University of Munich (TUM) for 18F-rhPSMA-7.3, an Investigational PET Imaging Agent, to support AI-based algorithms development. Siemens Healthineers intends to evaluate the data to improve its analytics and AI-based algorithms for prostate cancer across its innovative PET/CT imaging software. However, as AI technology continues to advance, it is likely to drive the growth of the PET scanners market in the future.

PET Scanners Market Report Highlights:

• PET-CT dominated the PET scanner market, holding the largest revenue share of 81.91% in 2023.
• The oncology segment is dominant, with the largest revenue share of 47.0% in 2023.
• The hospital segment held the largest revenue share of over 52.20% in 2023. Hospitals have comparatively high patient volume and access to advanced diagnostic technologies that are not available in other healthcare facilities, including advanced PET scanners, which allow them to provide comprehensive medical care.
• North America PET scanners market held the largest revenue share, over 34.11%, in 2023. Technological advancements in PET imaging for oncology and advanced diagnostic applications, along with the high demand for precision diagnostics, drive market growth significantly.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. PET Scanners Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Technical advances in PET imaging for advanced diagnostics applications and oncology
    • 3.2.1.2. Rising Demand For PET Analysis In Radio Pharmaceuticals
    • 3.2.1.3. Increasing Shift Towards Image-Guided Interventions
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Product Recall
• 3.3. PET Scanners Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pipeline Analysis

Chapter 4. PET Scanners Market: Modality Estimates & Trend Analysis

• 4.1. Global PET Scanners Market: Modality Dashboard
• 4.2. Global PET Scanners Market: Modality Movement Analysis
• 4.3. Global PET Scanners Market by Modality, Revenue
• 4.4. PET-CT
  • 4.4.1. PET-CT market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. PET-MRI
  • 4.5.1. PET-MRI market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. PET Scanners Market: Application Estimates & Trend Analysis

• 5.1. Global PET Scanners Market: Application Dashboard
• 5.2. Global PET Scanners Market: Application Movement Analysis
• 5.3. Global PET Scanners Market Estimates and Forecasts, By Application, Revenue (USD Million)
• 5.4. Oncology
  • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Cardiology
  • 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Neurology
  • 5.6.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. PET Scanners Market: End use Estimates & Trend Analysis

• 6.1. Global PET Scanners Market: End use Dashboard
• 6.2. Global PET Scanners Market: End use Movement Analysis
• 6.3. Global PET Scanners Market Estimates and Forecasts, by End use, Revenue (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Diagnostic Imaging Centers market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Academic & Research Institutes
  • 6.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. PET Scanners Market: Regional Estimates & Trend Analysis by Modality, Application and End use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key customers
  • 8.2.3. Key company market share analysis, 2023
  • 8.2.4. Canon Medical Systems
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. GE Healthcare
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Kindsway Biotech
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Koninklijke Phillips N.V.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Mediso Ltd.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. PerkinElmer
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Positron
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Shimadzu Corporation
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Siemens Healthineers AG
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives

관련자료